Lori Handy, MD, provides guidance in these areas including presentation before rash onset, when patients should be considered for the inpatient setting, and what treatment looks like.
|Videos|June 28, 2016
What is the Difference Between Staph and MRSA?
Author(s)Contagion Editorial Staff
Jeff Boyd, PhD, assistant professor of Biochemistry and Microbiology at Rutgers School of Environmental and Biological Sciences, explains the difference between Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus.
Advertisement
Jeff Boyd, PhD, assistant professor of Biochemistry and Microbiology at Rutgers School of Environmental and Biological Sciences, explains the difference between Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus.
Interview Transcript (slightly modified for readability)
“So methicillin[-resistant] Staph aureus is different than more commonly found Staphylococcus aureus in that it is resistant to an antibiotic called methicillin. Typically, it is resistant to all beta lactam antibiotics.
If you go into a clinic, a physician, if they treated you with a beta lactam antibiotic, methicillin-resistant Staphylococcus aureus would be able to resist the treatment, it would be able to survive in the presence of that antibiotic.”
Advertisement
Related to this article
IDSA/ESCMID panel member Henry Chambers, MD, explains why the new S aureus bacteremia guidance replaces the complicated vs uncomplicated label with risk stratification, and how the statements are akin to the stages of cancer in guiding treatment decisions associated with this bacteremia.
Jason Pogue, PharmD, BCPS, BCIDP, contextualizes preliminary data looking at this trial and other extended-spectrum beta-lactamase (ESBL) studies, which reopens the debate around carbapenem-sparing treatment options.
With a significant increase in rabies exposures this year, Rodney Rohde, PhD, talks about seeking medical attention after animal interactions as well as clinical treatment when people have been bit or scratched.
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Food expert Lynette Johnston, PhD, provides some context around the ongoing outbreak, discusses prevention, and compares 2026 food recalls with previous years.
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.
Advertisement
Advertisement
Trending on Contagion Live
1
Clinical Considerations for Measles: Presentation, Treatment, and Hospitalization
2
FAQ: Rising Rabies Exposure Calls PEP Decisions Back in Focus
3
Measles Update: October 2, 2026
4
New IDSA/ESCMID S aureus Bacteremia Consensus Statements: a Risk Stratification Framework
5